Synopsis of recent research by authors named "Ryan D Gentzler"
- Ryan D Gentzler's recent research primarily focuses on advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), investigating various treatment combinations involving immune checkpoint inhibitors and traditional chemotherapy agents to improve patient outcomes.
- His studies have explored the efficacy and safety of regimens combining novel therapies like cabozantinib and atezolizumab, as well as evaluating dynamic molecular biomarkers, such as circulating tumor DNA (ctDNA), for predicting responses to immunotherapy in real-world scenarios.
- Gentzler is also examining the immune landscape of NSCLC, particularly the interactions between natural killer (NK) cells and CD8 T cells in the context of decreased MHC class I expression, and assessing factors like opioid use on treatment effectiveness and overall survival in lung cancer patients.
